tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2020 Oct 22;7(11)
faa484.
doi: 10.1093/ofid/ofaa484. eCollection 2020 Nov.
Assessment of Respiratory Bacterial Coinfections Among Severe Acute Respiratory Syndrome Coronavirus 2-Positive Patients Hospitalized in Intensive Care Units Using Conventional Culture and BioFire, FilmArray Pneumonia Panel Plus Assay
Camille Kolenda[SUP] 1 [/SUP], Anne-Ga?lle Ranc[SUP] 1 [/SUP], Sandrine Boisset[SUP] 2 [/SUP], Yvan Caspar[SUP] 2 [/SUP], Anne Carricajo[SUP] 3 [/SUP], Aubin Souche[SUP] 1 [/SUP], Olivier Dauwalder[SUP] 1 [/SUP], Paul O Verhoeven[SUP] 3 [/SUP], Fran?ois Vandenesch[SUP] 1 [/SUP], Fr?d?ric Laurent[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Approximately 15% of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present with severe forms of the disease and require hospitalization in intensive care units, which has been associated with high mortality rates. The prevalence of bacterial infections in these patients is not well established, and more data are needed to guide empiric antibiotic therapy and improve patient outcomes.
Methods: In this prospective multicenter study, we assessed bacterial coinfections identified in culture from 99 French patients infected by SARS-Cov-2 and hospitalized in intensive care units. We concomitantly evaluated an innovative molecular diagnostic technology technique, the BioFire, FilmArray Pneumonia Panel plus (FA-pneumo) assay, to identify these coinfections at an early stage, and its concordance with conventional culture.
Results: We showed that a bacterial coinfection was detected in 15% of patients based on conventional culture. Staphylococcus aureus and Haemophilus influenzae were the most prevalent pathogens. The sensitivity of FA-pneumo compared with culture was 100%. In contrast, the specificity varied between 88.4% and 100% according to the pathogen, and our results highlighted that 60.5% of bacterial targets reported using this assay were not recovered by culture; 76.9% of discordant results corresponded to bacteria belonging to commensal oral flora and/or reported with ≤10[SUP]5[/SUP] copies/mL bacterial nucleic acids.
Conclusions: Based on its excellent sensitivity, the FA-pneumo assay is useful to rule out bacterial coinfections in the context of severe SARS-CoV-2 infection and avoid the inappropriate prescription of antibiotics. However, positive tests should be interpreted carefully, taking into consideration deoxyribonucleic acid bacterial load and all clinical and biological signs.
Keywords: BioFire; COVID-19; FilmArray; bacterial coinfection; intensive care units.
. 2020 Oct 22;7(11)
faa484.doi: 10.1093/ofid/ofaa484. eCollection 2020 Nov.
Assessment of Respiratory Bacterial Coinfections Among Severe Acute Respiratory Syndrome Coronavirus 2-Positive Patients Hospitalized in Intensive Care Units Using Conventional Culture and BioFire, FilmArray Pneumonia Panel Plus Assay
Camille Kolenda[SUP] 1 [/SUP], Anne-Ga?lle Ranc[SUP] 1 [/SUP], Sandrine Boisset[SUP] 2 [/SUP], Yvan Caspar[SUP] 2 [/SUP], Anne Carricajo[SUP] 3 [/SUP], Aubin Souche[SUP] 1 [/SUP], Olivier Dauwalder[SUP] 1 [/SUP], Paul O Verhoeven[SUP] 3 [/SUP], Fran?ois Vandenesch[SUP] 1 [/SUP], Fr?d?ric Laurent[SUP] 1 [/SUP]
Affiliations
- PMID: 33204762
- PMCID: PMC7654374
- DOI: 10.1093/ofid/ofaa484
Abstract
Background: Approximately 15% of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present with severe forms of the disease and require hospitalization in intensive care units, which has been associated with high mortality rates. The prevalence of bacterial infections in these patients is not well established, and more data are needed to guide empiric antibiotic therapy and improve patient outcomes.
Methods: In this prospective multicenter study, we assessed bacterial coinfections identified in culture from 99 French patients infected by SARS-Cov-2 and hospitalized in intensive care units. We concomitantly evaluated an innovative molecular diagnostic technology technique, the BioFire, FilmArray Pneumonia Panel plus (FA-pneumo) assay, to identify these coinfections at an early stage, and its concordance with conventional culture.
Results: We showed that a bacterial coinfection was detected in 15% of patients based on conventional culture. Staphylococcus aureus and Haemophilus influenzae were the most prevalent pathogens. The sensitivity of FA-pneumo compared with culture was 100%. In contrast, the specificity varied between 88.4% and 100% according to the pathogen, and our results highlighted that 60.5% of bacterial targets reported using this assay were not recovered by culture; 76.9% of discordant results corresponded to bacteria belonging to commensal oral flora and/or reported with ≤10[SUP]5[/SUP] copies/mL bacterial nucleic acids.
Conclusions: Based on its excellent sensitivity, the FA-pneumo assay is useful to rule out bacterial coinfections in the context of severe SARS-CoV-2 infection and avoid the inappropriate prescription of antibiotics. However, positive tests should be interpreted carefully, taking into consideration deoxyribonucleic acid bacterial load and all clinical and biological signs.
Keywords: BioFire; COVID-19; FilmArray; bacterial coinfection; intensive care units.